Vectura Group Share Price (VEC)

103.35 -1.05 (-1.01%) delayed: 1:31PM BST
Bid price 103.30 Open price 105.00
Ask price 103.40 Prev close 104.40
High price 105.50 Spread 0.10%
Low price 103.30 Volume 628,032

Register now for FREE live Vectura Group share prices, Vectura Group stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Vectura Group Level 2 Data, indepth research tools and investor commentary for Vectura Group (VEC) and other London Stock Exchange equities.

Vectura Group Share Price Chart

Advanced Charts >>

Register now for FREE Vectura Group share price charts

Vectura Group Share Price Information

Name Vectura Group Epic VEC
Sector Pharmaceuticals & Biotechnology ISIN GB00B01D1K48
Activites Vectura Group plc develops inhaled therapies principally for the treatment of respiratory diseases. Vectura's main products target diseases such as asthma and chronic obstructive pulmonary disease (COPD), a growing market that is currently estimated to be worth in excess of $25bn. Vectura has seven products marketed by its partners and a portfolio of drugs in clinical and pre-clinical development, a number of which have been licensed to major pharmaceutical companies. Vectura has development collaborations and licence agreements with several pharmaceutical companies, including Novartis, Sandoz (the generics arm of Novartis), Baxter and GlaxoSmithKline (GSK). Vectura seeks to develop certain programmes itself where this will optimise value. Vectura's formulation and inhalation technologies are available to other pharmaceutical companies on an out-licensing basis where this complements Vectura's business strategy. Index FTSE 250

Vectura Group Key Numbers

Latest Share Price (p) 103.35 Net Gearing (%) 9.01
Market Capitalisation (£m) 705.16 Gross Gearing (%) 19.94
Shares in issue (m) 679.34 Debt Ratio 12.69
P/E Ratio -19.59 Debt-to-Equity Ratio 0.58
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.25
Dividend Yield (%) 0.00 Price to book value 1.04
Dividend cover (x) 0.00 ROCE (%) -5.17
Earning per share (p) -5.30 EPS Growth (%) -541.67
52 week high / low 166.90 / 88.90 DPS Growth (%) n/a

Vectura Group Director Deals

Dec.Date Type Director Pos No. of Shares
13/09/2017 BUY Bruno Angelici CH 70,000
12/09/2017 BUY Andrew Derodra FD 158
08/09/2017 BUY James Ward-Lilley CEO 82,918
08/09/2017 BUY James Ward-Lilley CEO 82,918
07/09/2017 BUY Andrew Derodra FD 82,000

More Vectura Group Director Deals >>

Vectura Group Company News

13:20 18/09/2017

Holding(s) in Company

RNS Number : 0548R Vectura Group plc 18 September 2017   TR-1: S tandard form for notification of major holdings   1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii : Vectura...

10:15 13/09/2017

Director Deals - Vectura Group PLC (VEC)

Bruno Angelici, Chairman, bought 70,000 shares in the company on the 12th September 2017 at a price of 96.66p. The Director now holds 162,903 shares. Story provided by Director deals data provided by

09:43 13/09/2017

Director/PDMR Shareholding

RNS Number : 6231Q Vectura Group plc 13 September 2017   Vectura Group plc Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them (in accordance with the Market Abuse Regulations)...

More Vectura Group Company News >>

Register now for FREE Vectura Group company news

Vectura Group Share Price Discussions

more than 1 year ago


Powered by IST's

Register now for FREE Vectura Group share price discussions